NAV
$89.59
AUM
$16.9B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.88
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +9.23% | +0.95% | +4.29% | +22.34% | +19.50% | +10.42% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML | ASML Holding NV ADR | 1.31% |
| 2 | ROP.SW | Roche Holding AG Ordinary Shares new | 0.94% |
| 3 | SHEL | Shell PLC ADR (Representing - Ordinary Shares) | 0.83% |
| 4 | HSBC | HSBC Holdings PLC ADR | 0.82% |
| 5 | BHP | BHP Group Ltd ADR | 0.59% |
| 6 | NVS | Novartis AG ADR | 0.55% |
| 7 | BBVA | Banco Bilbao Vizcaya Argentaria SA ADR | 0.52% |
| 8 | SAF.PA | Safran SA | 0.52% |
| 9 | UBSG.SW | UBS Group AG Registered Shares | 0.50% |
| 10 | ALV.DE | Allianz SE | 0.50% |
The fund invests primarily in a diverse group of non-U.S. companies across countries, market sectors and industry groups. It may invest in companies of all market capitalizations. Under normal market conditions, the fund will invest at least 80% of its assets in equity securities. It also may invest in derivative instruments such as futures contracts, currency forwards, and swap agreements.
Inception Date: 2019-09-24